In this thesis are described recent advances in the field of iodine (I/III) catalysis. In particular, this chemistry is used for the formation of new C-N bonds, in search of greener alternatives to the existent methodologies for the formation of racemic and enantiopure 1,2-diamines. These compounds are relevant for their biological role and in the fields of organic and pharmaceutical chemistry. Recently, the chemistry of hypervalent iodine (III) and iodine (I/III) catalysis have been proposed as adequate ways for the formation of diamines.
Initially, a new racemic catalytic diamination was developed, which allowed the diamination of styrenes in good yields in a practical way and without the use of stochiometric hypervalent iodine reagents. Bismesylamide and Bistosylamide could be incorporated as nucleophiles for the diamination reaction.
Afterwards, a scale-up of the synthesis of Ishihara-Muñiz pre-catalysts was performed. During this upscaling, a meso-form of the pre-catalyst for the diamination reaction was detected. When the formation of this species could be avoided, the diamines were obtained in the highest ever reported ee using hypervalent iodine chemistry.
Finally, a proof of concept was developed. The synthesis of a C1-symmetric pre-catalyst with half of the stereogenic centres than its predecessors showed good yields in the diamination reaction. Additionally, most part of the enantiodifferentiation induced by previous C2-symmetric pre-catalysts was maintained.
—
According to the last information received from ICIQ’s safety department about the measures to prevent and contain COVID-19 at ICIQ, a total of 70 people is now the maximum capacity allowed in the Auditorium, so the Thesis Defense will be finally held in the Auditorium as well as through ZOOM platform too.
For those who prefer to follow the ceremony in a virtual format, please remember that you should register here.
If you are interested in attending in the Auditorium, please, fill in this registration form to be sure that we do not exceed the maximum capacity. (It will be assigned on a first-come/first served basis). We will confirm your acceptance through an e-mail as soon as possible after your registration.
Join our team to work with renowned researchers, tackle groundbreaking
projects and contribute to meaningful scientific advancements